Acute Vision Loss Management

Immediate Actions and Diagnostic Considerations

• The American Heart Association and American Stroke Association recommend that central retinal artery occlusion be treated as a medical emergency, requiring immediate referral to an emergency department or stroke center without attempting further testing, as it represents an acute ischemic stroke with high risk of concurrent cerebrovascular events 1, 2
• The American Academy of Ophthalmology recommends transfer to a certified stroke center or emergency department immediately, without delay for additional ophthalmologic testing, and direct communication with the stroke team is essential for appropriate triage 2, 3
• Antiplatelet therapy should be started without delay in patients with central retinal artery occlusion 2
• Intravenous tissue plasminogen activator may be considered for patients presenting within 4.5 hours of symptom onset, according to the American Heart Association 1, 4
• Brain MRI with diffusion-weighted imaging within 24 hours can identify concurrent silent brain infarctions, which occur in up to 25% of patients, as recommended by the American College of Radiology 4, 5
• Vascular imaging of carotid arteries can identify clinically significant stenosis, found in up to 70% of patients, according to the American College of Cardiology 4, 5
• For patients over 50 years, urgent ESR and CRP tests can help rule out giant cell arteritis, which requires immediate corticosteroid therapy, as recommended by the American College of Rheumatology 4, 5

Giant Cell Arteritis Diagnosis and Management

• The American College of Rheumatology recommends that giant cell arteritis be ruled out immediately in any patient over 50 years with acute vision loss, as it can cause irreversible bilateral blindness 4, 5
• Jaw claudication is a specific symptom of giant cell arteritis, with a likelihood ratio of 4.90, according to the American College of Rheumatology 5
• ESR >60 mm/h has a high likelihood ratio for giant cell arteritis, as recommended by the American College of Rheumatology 5
• High-dose IV corticosteroids should be started immediately, before biopsy confirmation, to prevent vision loss in the fellow eye, according to the American College of Rheumatology 4

System-Level Approach to Acute Vision Loss

• The American Heart Association recommends that all acute vision loss be treated as an emergency, requiring same-day evaluation, and the window for effective intervention is typically 4.5-6 hours for vascular occlusions 1, 2
• The American Academy of Ophthalmology recommends developing local networks connecting optometrists, ophthalmologists, and stroke neurologists to improve acute vision loss management 3, 5
• Public education campaigns should include vision loss as a stroke warning sign, using the "BE-FAST" acronym instead of "FAST", as recommended by the American Heart Association 2, 3

Management of Acute Central Retinal Artery Occlusion

Guideline Recommendations

• The American Heart Association recommends intravenous alteplase (tPA) 0.9 mg/kg (10% bolus over 1 minute, remainder over 59 minutes) may be considered within 4.5 hours after thorough benefit/risk discussion for patients with acute central retinal artery occlusion 6, 7
• The American Heart Association suggests immediate triage to emergency department/stroke center without delay for patients with acute central retinal artery occlusion 6, 7
• The American Heart Association recommends treatment as a stroke equivalent requiring urgent evaluation for patients with acute central retinal artery occlusion 6, 7

Diagnostic Workup

• The American Heart Association recommends brain CT without contrast to exclude hemorrhage for patients with acute central retinal artery occlusion 7
• The American Heart Association suggests cardiac monitoring for atrial fibrillation for patients with acute central retinal artery occlusion 8, 9
• The American Heart Association recommends echocardiography for cardioembolic source for patients with acute central retinal artery occlusion 8, 9

Secondary Prevention

• The American Heart Association recommends antiplatelet therapy: aspirin 81 mg daily or clopidogrel 75 mg daily for patients with acute central retinal artery occlusion 9
• The American Heart Association suggests statin therapy for risk factor modification for patients with acute central retinal artery occlusion 8, 9
• The American Heart Association recommends carotid revascularization if high-grade symptomatic stenosis identified for patients with acute central retinal artery occlusion 8, 9
• The American Heart Association suggests anticoagulation if atrial fibrillation or cardioembolic source detected for patients with acute central retinal artery occlusion 8, 9

Acute and Secondary Management of Occipital Infarct with Visual Loss

Acute Stroke Protocol

• Immediate activation of a stroke protocol for patients with occipital infarct and visual loss is required, as these represent time‑sensitive ischemic strokes. American College of Radiology recommendation. 10

Diagnostic Imaging

• Brain MRI with diffusion‑weighted imaging (DWI) should be performed within 24 hours to delineate the full extent of infarction and to detect concurrent silent cerebral infarcts. American College of Radiology recommendation. 10

Hospitalization Criteria

Neuro‑Imaging Findings

• Hospital admission is indicated when DWI‑MRI shows evidence of an acute cerebral infarction. Ophthalmology guideline. 11

Vascular Findings

• Admission is indicated for large‑artery atherosclerosis (≥50‑70 % internal carotid or vertebral artery stenosis) identified on non‑invasive vascular imaging. Ophthalmology guideline. 11

Clinical Course

• Recurrent crescendo TIAs warrant inpatient care. Ophthalmology guideline. 11
• Inability to arrange expedited outpatient follow‑up mandates admission. Ophthalmology guideline. 11

Cardiac Evaluation

• Detection of an embolic source on cardiac work‑up (e.g., atrial fibrillation, left‑atrial thrombus) requires hospitalization. Ophthalmology guideline. 12

Secondary Prevention

Pharmacologic Measures

• All discharged patients should receive high‑intensity statin therapy for lipid management and plaque stabilization. Ophthalmology guideline. 13
• Blood‑pressure targets after occipital infarct are <140/90 mm Hg (or <130/80 mm Hg in diabetics). Ophthalmology guideline. 13

Surgical Intervention for Carotid Stenosis

• Symptomatic carotid stenosis ≥50‑70 % should be treated with carotid endarterectomy within 2 weeks, as benefit declines sharply after this period. Ophthalmology guideline. 13
• Internal carotid artery stenosis ≥50 % mandates admission to a stroke unit for urgent revascularization consideration. Ophthalmology guideline. 13

Follow‑Up

• Outpatient neurology follow‑up with stroke expertise must be arranged within 2 weeks of discharge to review investigations and optimize secondary‑prevention strategies. Ophthalmology guideline. 13

Ophthalmologic Management

• Panretinal photocoagulation (PRP), with or without anti‑VEGF therapy, is recommended when iris or retinal neovascularization develops, although it does not improve visual acuity. Ophthalmology guideline. [14][15]

Cardiovascular Risk Assessment

• New significant cardiovascular conditions are identified in up to 70 % of patients with symptomatic arterial occlusions, highlighting the need for aggressive cardiovascular risk evaluation. Ophthalmology guideline. [14][15]

Transfer Recommendations

• Patients suspected of having a vascular etiology for visual loss must be transferred immediately to a certified stroke center; additional ophthalmologic testing must not delay transfer. Ophthalmology guideline. [13][16]